Go Deep
Insmed Incorporated
Insmed Incorporated Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 5,665 | -24.5 | 29.00 | 0.98 | 9,729.39 |
| Oct 2026 | 6,008 | -24.0 | 28.41 | 0.98 | 9,436.19 |
| Oct 2026 | 6,793 | -23.6 | 27.90 | 0.98 | 9,217.67 |
| Oct 2026 | 6,625 | -23.9 | 28.19 | 0.98 | 9,284.92 |
| Oct 2026 | 6,387 | -24.0 | 28.60 | 0.98 | 9,421.08 |
| Oct 2026 | 6,881 | -23.5 | 27.75 | 0.98 | 9,118.21 |
| Oct 2026 | 7,045 | -23.2 | 27.47 | 0.98 | 9,035.05 |
| Oct 2026 | 6,981 | -23.3 | 27.58 | 0.98 | 9,071.08 |
| Oct 2026 | 7,255 | -22.8 | 27.11 | 0.98 | 8,894.51 |
| Oct 2026 | 7,084 | -23.2 | 27.41 | 0.98 | 8,972.79 |
Insmed Incorporated Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 425,486,000.0 | 305,964,000.0 | 263,843,000.0 | 142,342,000.0 |
| Net Profit | -13,242,000.0 | -163,563,000.0 | -328,485,000.0 | -370,021,000.0 |
| EPS | -0.1 | -0.8 | -1.5 | -1.8 |
Insmed Incorporated Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 606,423,000.0 | 363,707,000.0 | 305,208,000.0 | 245,358,000.0 | — |
| Net Profit | -1,276,775,000.0 | -913,772,000.0 | -749,567,000.0 | -481,534,000.0 | — |
| EPS | -6.4 | -5.6 | -5.3 | -3.9 | — |
Insmed Incorporated Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,264,558,000.0 | 2,025,231,000.0 | 1,329,837,000.0 | 1,656,435,000.0 | — |
| Total Liabilities | 1,525,582,000.0 | 1,739,852,000.0 | 1,661,760,000.0 | 1,568,484,000.0 | — |
| Total Equity | 738,976,000.0 | 285,379,000.0 | -331,923,000.0 | 87,951,000.0 | — |
Owes vs Owns
Insmed Incorporated owed $0.64 for every $1 it owned in Jun 2026, down from $0.95 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.64× | 0.67× | 0.86× | 1.25× | 0.95× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Insmed Incorporated Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 63.1%Receivables 6.2%Inventory 5.8%Fixed assets (tangible) 6.1%Intangible assets 10.3%Other assets 8.3%
How it's funded — Dec 2025
Short-term debt 0.6%Long-term debt 23.9%Payables 3.5%Other liabilities 39.4%Shareholders' equity 32.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,430.0 | 1,433.8 | 780.4 | 1,148.3 |
| Receivables | 140.9 | 52.0 | 41.2 | 29.7 |
| Inventory | 132.1 | 98.6 | 83.2 | 69.9 |
| Fixed assets (tangible) | 139.2 | 115.6 | 104.4 | 102.1 |
| Intangible assets | 233.8 | 194.8 | 199.8 | 204.9 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 188.6 | 130.5 | 120.8 | 101.6 |
| Liabilities & equity | ||||
| Short-term debt | 12.8 | 12.3 | 10.6 | 8.1 |
| Long-term debt | 541.0 | 1,103.4 | 1,155.3 | 1,125.2 |
| Payables | 79.9 | 73.0 | 65.4 | 50.5 |
| Other liabilities | 891.9 | 551.1 | 430.4 | 384.6 |
| Shareholders' equity | 739.0 | 285.4 | -331.9 | 88.0 |
| Net tangible assets | 505.2 | 90.6 | -531.7 | -116.9 |
Insmed Incorporated Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -935,014,000.0 | -683,882,000.0 | -536,247,000.0 | -400,439,000.0 | — |
| Investing Activities | -64,575,000.0 | -583,175,000.0 | -223,604,000.0 | -34,584,000.0 | — |
| Financing Activities | 954,073,000.0 | 1,341,020,000.0 | 168,439,000.0 | 793,273,000.0 | — |